J.P. Morgan analyst David Adlington maintained a Sell rating on Carl Zeiss Meditec (0DHC – Research Report) today. The company’s shares closed ...

Carl Zeiss Meditec AG ( ETR:AFX ), is not the largest company out there, but it saw a significant share price rise ...

Carl Zeiss Meditec shows solid recovery signs, especially in China/US, with strong growth in equipment and consumables. Read ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Carl Zeiss Meditec AG (CZMWF) reported a 3.2% increase in revenue for Q1 2025 compared to the same period last year. The company saw a significant recovery in order entry, reaching 522 million ...

Investing.com -- Shares of Carl Zeiss Meditec AG (ETR:AFX) dropped 6% today after the company reported its first-quarter revenues, which showed a slight increase of 1.2% versus the Vara consensus ...

Carl Zeiss Meditec AG (“Carl Zeiss”) is proud to honor EuroEyes International Eye Clinic Limited (“EuroEyes International” or the “Company”) for achieving the prestigious title of the most AT LISA® ...

O n Thursday, JPMorgan analyst Anchal Verma adjusted the price target on Carl Zeiss Meditec AG (AFX:GR) (OTC: CZMWY) to €41.00, up from the previous €40.00, while maintaining an Underweight ...

Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow enhancements. JENA, (Germany), SHANGHAI, (China), | 27 ...